The genetic basis for measles vaccine failure

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 93, Issue 445, 2004, Pages 43-46

  Jacobson, R M ^a   Poland, G A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Genetics; Measles; Measles vaccine; Population; Variation (genetics)

Indexed keywords

HLA ANTIGEN; MEASLES VACCINE;

ALLELE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; CLINICAL TRIAL; CONFERENCE PAPER; DIZYGOTIC TWINS; DRUG EFFICACY; EPIDEMIC; FOLLOW UP; GENETIC ANALYSIS; GEOGRAPHIC DISTRIBUTION; HLA SYSTEM; HUMAN; IMMUNE SYSTEM; MALNUTRITION; MEASLES; MONOZYGOTIC TWINS; PASSIVE IMMUNIZATION; POPULATION RESEARCH; PRIORITY JOURNAL; TREATMENT FAILURE; VACCINATION;

EID: 2342633723     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2004.tb03055.x     Document Type: Conference Paper

References (16)

1. Centers for Disease Control and Prevention. Measles at an international gymnastics competition - Indiana, 1991 MMWR Morb Mortal Wkly Rep 1992; 41: 109-11
2. Centers for Disease Control and Prevention. Measles - United States, 1992 MMWR Morb Mortal Wkly Rep 1993; 42: 378-81
3. Anders JF, Jacobson RM, Poland GA, Jacobsen SJ, Wollan PC. Secondary failure rates of measles vaccines: a metaanalysis of published studies. Pediatr Infect Dis J 1996; 15: 62-6
4. Brunell PA, Weigle K, Murphy MD, Shehab Z, Cobb E. Antibody response following measles-mumps-rubella vaccine under conditions of customary use. JAMA 1983; 250: 1409-12
5. Bautista-Lopez N, Ward BJ, Mills E, McCormick D, Martel N, Ratnam S. Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination. Vaccine 2000; 18: 1393-401
6. Mitchell LA, Tingle AJ, Decarie D, Lajeunesse C. Serologic responses to measles, mumps, and rubella (MMR) vaccine in healthy infants: failure to respond to measles and mumps components may influence decisions on timing of the second dose of MMR. Can J Public Health 1998; 89: 325-8
7. Orenstein WA, Hermann K, Albrecht P, Bernier R, Holmgreen P, Bart KJ, et al. Immunity against measles and rubella in Massachusetts schoolchildren. Dev Biol Stand 1986; 65: 75-83
8. Poland GA, Jacobson RM, Vierkant RA, Colbourne SA, Thampy AM, Pankratz VS, et al. Effect of differing immunization policies on circulating measles antibody levels in US and Canadian children. Mayo Clin Proc 2002; 77: 446-52
9. Tan PL, Jacobson RM, Poland GA, Jacobsen SJ, Pankratz VS. Twin studies of immunogenicity - determining the genetic contribution to vaccine failure. Vaccine 2001; 19: 2434-9
10. Tan P, Jacobson R. The similarity method for diagnosis of zygosity in twins. Singapore Pediatric Journal 2000; 42: 21-5
11. Hayney MS, Poland GA, Jacobson RM, Rabe D, Schaid DJ, Jacobsen SJ, et al. Relationship of HLA-DQA1 alleles and humoral antibody following measles vaccination. Int J Infect Dis 1998; 2: 143-6
12. Hayney MS, Poland GA, Jacobson RM, Schaid DJ, Lipsky JJ. The influence of the HLA-DRB1*13 allele on measles vaccine response. J Invest Med 1996; 44: 261-3
13. Poland GA, Jacobson RM, Schaid D, Moore SB, Jacobsen SJ. The association between HLA class I alleles and measles vaccine-induced antibody response: evidence of a significant association. Vaccine 1998; 16: 1869-71
14. Poland GA, Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, et al. Identification of an association between HLA class II alleles and low antibody levels after measles immunization. Vaccine 2001; 20: 430-8
15. St Sauver JL, Ovsyannikova IG, Jacobson RM, Jacobsen SJ, Vierkant RA, Schaid DJ, et al. Associations between human leukocyte antigen homozygosity and antibody levels to measles vaccine. J Infect Dis 2002; 185: 1545-9
16. Jacobson RM, Poland GA, Vierkant RA, Pankratz VS, Schaid DJ, Jacobsen SJ, et al. The association of class I HLA alleles and antibody levels following a single dose of measles vaccine. Hum Immunol 2003; 64: 103-9